Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

The main objective of the study was a pharmacological review of the bioactive constituents of the above mentioned tree nuts, as effective supplements and natural medicinal foods in Alzheimer’s Disease (AD) patients.
 
PubMed and ScienceDirect databases were used to search AD-related researches on these tree nuts from year 2000 to present. Results showed that almonds, hazelnuts and walnuts provide macronutrients, micronutrients, and phytochemicals which may affect several pathways in AD pathogenesis, such as oxidative stress, cholesterol lowering and anti-inflammatory properties, among others.
 
These nuts have been recommended for their brain-protective activity and particularly reversing brain atrophy in the case of hazelnut. The study concluded that the use of these tree nuts could be more considered in scientific researches as effective nutrients for prevention or even management of AD, thanks to their nutritional composition, specially to their phytochemicals content.
 
Gorji, N., Moeini, R., & Memariani, Z. (2017). Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: a neuropharmacological review of their bioactive constituents. Pharmacological research. DOI:10.1016/j.phrs.2017.12.003

Join us

Sign up to become a member of the INC and discover the benefits of INC membership. Or subscribe and have access to our magazine, industry newsletters and industry directory.

Privacy Preference Center